Phreesia, Inc. (NYSE:PHR) SVP Sells $22,539.00 in Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 1,100 shares of Phreesia stock in a transaction dated Friday, October 18th. The shares were sold at an average price of $20.49, for a total value of $22,539.00. Following the completion of the transaction, the senior vice president now directly owns 200,207 shares in the company, valued at $4,102,241.43. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

David Linetsky also recently made the following trade(s):

• On Tuesday, October 15th, David Linetsky sold 2,011 shares of Phreesia stock. The shares were sold at an average price of $21.03, for a total transaction of $42,291.33.
• On Thursday, September 19th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $24.04, for a total transaction of $576.96.
• On Tuesday, September 17th, David Linetsky sold 36 shares of Phreesia stock. The shares were sold at an average price of $24.77, for a total transaction of $891.72.
• On Tuesday, September 10th, David Linetsky sold 1,716 shares of Phreesia stock. The stock was sold at an average price of $23.25, for a total transaction of $39,897.00.

Phreesia Price Performance

Shares of NYSE PHR opened at $19.60 on Wednesday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $1.13 billion, a price-to-earnings ratio of -10.89 and a beta of 0.93. Phreesia, Inc. has a twelve month low of $12.05 and a twelve month high of $29.16. The business has a 50 day simple moving average of $23.16 and a 200-day simple moving average of $22.38.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share for the quarter, beating the consensus estimate of ($0.37) by $0.06. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. The firm had revenue of $102.12 million during the quarter, compared to analyst estimates of $101.76 million. As a group, equities research analysts expect that Phreesia, Inc. will post -1.23 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Canaccord Genuity Group reissued a “buy” rating and set a $34.00 target price on shares of Phreesia in a research report on Thursday, September 5th. DA Davidson reissued a “buy” rating and issued a $32.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research report on Thursday, September 5th. Robert W. Baird boosted their price target on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a research note on Friday, September 6th. Finally, KeyCorp lowered their price objective on Phreesia from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, July 11th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, Phreesia has an average rating of “Moderate Buy” and a consensus price target of $29.42.

Institutional Investors Weigh In On Phreesia

Several institutional investors and hedge funds have recently bought and sold shares of the business. Trust Point Inc. raised its position in shares of Phreesia by 3.5% during the 3rd quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock worth $408,000 after purchasing an additional 607 shares during the period. Ensign Peak Advisors Inc boosted its holdings in shares of Phreesia by 3.2% during the second quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock valued at $477,000 after acquiring an additional 700 shares during the period. ProShare Advisors LLC grew its position in shares of Phreesia by 8.6% during the first quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock worth $228,000 after acquiring an additional 751 shares during the last quarter. Rhumbline Advisers increased its holdings in shares of Phreesia by 1.0% in the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after acquiring an additional 853 shares during the period. Finally, Swiss National Bank lifted its position in Phreesia by 1.0% in the 1st quarter. Swiss National Bank now owns 104,300 shares of the company’s stock valued at $2,496,000 after purchasing an additional 1,000 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.